Back to Newsroom

Arena Pharmaceuticals Reports Eisai’s Launch of National Television Advertising Campaign for BELVIQ (lorcaserin HCl) CIV for Chronic Weight Management

SAN DIEGO, April 14, 2014 /PRNewswire/ — Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today reported that Eisai Inc. has launched a national television advertising campaign for BELVIQ® (lorcaserin HCl), an FDA-approved prescription treatment for chronic weight management. The initial advertisement, which illustrates the struggles that many people face with hunger and body weight, will air on Lifetime, Oxygen, AMC and numerous other networks. BELVIQ is presented as a targeted approach to weight loss, that, when combined with diet and increased activity, may help patients lose weight and keep it off.

Click here to read more